IASLC CEO Karen Kelly, MD, recently spoke with ILCN about the 2024 World Conference on Lung Cancer, which begins today at the San Diego Convention Center. In the following Q&A, hear her thoughts on the importance of understanding the field’s history as well as recent initiatives aimed at continuing to move the field forward. ILCN: Obviously, the big news at the 2024 World Conference on Lung Cancer is the IASLC’s 50th anniversary.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Erin Jungmeyer
Opening Plenary to Shine Spotlight on Solutions to Improve Health Equity
Evolving scientific advances have led to significant gains in survival and improvements in morbidity and mortality for patients with lung cancer in recent years. However, improved treatments are only effective when they reach patients. And unfortunately, in many parts of the world, patients still do not have access to the latest therapies.
2024 IASLC CT Screening Symposium
ILCN: What is your presentation about? Dr. Rzyman: The current status of lung cancer screening implementation in Central Europe and the Nordic Countries is based on direct information from key persons involved in the process in each country. Central/Eastern Europe with its 157 million inhabitants and Nordic Countries with their 15 million inhabitants are significant European regions with high rates of smoking addiction, with potentially several million people at risk of developing lung cancer.
LATAM Workshop: Challenges and Future of Lung Cancer in Latin America
ILCN: What is your presentation about? Dr. Faroni: My presentation is about the challenges of radiation oncology in Latin America, focusing on economic disparities and difficulties in accessing technology. ILCN: Why is this topic timely or important in 2024? Dr. Faroni: This topic is always relevant, particularly in developing countries, because there is a disparity between such countries and their patients with different socioeconomic statuses.
Incoming IASLC President Hopes to Continue to Grow the Association’s International Reach
Incoming IASLC President Paul Van Schil, MD, PhD, recently spoke to ILCN about his upcoming presidential term, which officially begins during the 2023 World Conference on Lung Cancer.
IASLC Lectureships Highlight Contributions of Leaders in Thoracic Oncology
Each year, IASLC presents several awards to clinicians and investigators who have made significant contributions to the treatment of patients with lung cancer. Awardees are invited to the World Conference on Lung Cancer to receive their awards and deliver a forward-looking, state-of-the-art lecture about their area of expertise. For the first time at WCLC 2023, these award lectures will take place during one dedicated plenary session.
2023 Distinguished Service Awards Presented
During the Opening Plenary Session of the 2023 World Conference on Lung Cancer, four leaders in the field of thoracic oncology were celebrated for their contributions. These annual awards not only honor the recipients for their lifelong achievements and dedication to the profession; they also pays tribute to the lung cancer legends for which the awards are named. The Adi F.
Welcome to Singapore and the 2023 World Conference on Lung Cancer
IASLC CEO Karen Kelly, MD, an internationally recognized lung cancer expert, recently spoke with ILCN about the 2023 World Conference on Lung Cancer, which begins today at the Suntec Singapore Convention & Exhibition Center. In the following Q&A, get some behind-the-scenes insights, hear her tips for making the most of WCLC 23, and find out what she’s looking forward to in Singapore.
STARS Program Trains Patients, Caregivers to be Research Advocates
The IASLC Supportive Training for Advocates on Research & Science (STARS) program aims to increase the number of patient research advocates (PRAs) in the thoracic oncology community. PRAs are patients or caregivers who have had a personal experience with cancer. They engage in activities related to cancer research and provide patient perspectives to improve research relevance, quality, participation, education, funding, and dissemination.
Join This Evening’s Events to Catch-up with Colleagues, Celebrate Early-Career Researchers and Award Winners
After a day of workshops, symposia, and the Opening Plenary, make time to include some opportunities to reconnect and recharge on your agenda for this evening. First, be sure to attend the IASLC Award Ceremony, which takes place from 17:00 – 18:00 SGT tonight, Saturday, September 9, in room 405B. This annual event celebrates the association’s early-career researchers and award winners. Refreshments will be provided, and the event will be live streamed for virtual attendees.
Know Before You Go: Getting To—And Around—Singapore - ILCN.org (ILCN/WCLC)
The IASLC 2023 World Conference on Lung Cancer will take place at the Suntec Singapore Convention & Exhibition Centre. Singapore is an island city-state in Southeast Asia. Known as a global hub for healthcare, education, entertainment, and finance, Singapore is often recognized as a top destination for international meetings. Getting Around Suntec Singapore is in the heart of Singapore’s central business district, which is connected to three Mass Rapid Transit (MRT) lines and major highways.
IASLC Staging Project Finalizing Recommendations for 9th Edition of TNM Classification System
Editor’s Note: For more on staging and prognostic factors, read a new commentary on the challenges—and possible alternative approaches—to improving nodal staging. For the past 20 years, the IASLC Staging Project has provided evidence-based recommendations for the TNM Classification for Thoracic Cancers, which is published by the Union for International Cancer Control (UICC) and the American Joint Committee on Cancer (AJCC).
IASLC President Shares Her Excitement as Lung Cancer Community Gathers Face-to-Face
IASLC President Heather Wakelee, MD, FASCO, who joined the association’s board of directors in 2015, is a professor of medicine and chief of the Oncology Division at Stanford University, Stanford, California, where she also serves as deputy director of the Stanford Cancer Institute.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Erin
Contact Erin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack